Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimates
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.
Department of Infectious Diseases, Karolinska University Hospital, Huddinge, Sweden.
Visa övriga samt affilieringar
2022 (Engelska)Ingår i: Clinical & Translational Immunology (CTI), E-ISSN 2050-0068, Vol. 11, nr 3, artikel-id e1379Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Objectives: Population-level measures of seropositivity are critical for understanding the epidemiology of an emerging pathogen, yet most antibody tests apply a strict cutoff for seropositivity that is not learnt in a data-driven manner, leading to uncertainty when classifying low-titer responses. To improve upon this, we evaluated cutoff-independent methods for their ability to assign likelihood of SARS-CoV-2 seropositivity to individual samples. Methods: Using robust ELISAs based on SARS-CoV-2 spike (S) and the receptor-binding domain (RBD), we profiled antibody responses in a group of SARS-CoV-2 PCR+ individuals (n = 138). Using these data, we trained probabilistic learners to assign likelihood of seropositivity to test samples of unknown serostatus (n = 5100), identifying a support vector machines-linear discriminant analysis learner (SVM-LDA) suited for this purpose. Results: In the training data from confirmed ancestral SARS-CoV-2 infections, 99% of participants had detectable anti-S and -RBD IgG in the circulation, with titers differing > 1000-fold between persons. In data of otherwise healthy individuals, 7.2% (n = 367) of samples were of uncertain serostatus, with values in the range of 3-6SD from the mean of pre-pandemic negative controls (n = 595). In contrast, SVM-LDA classified 6.4% (n = 328) of test samples as having a high likelihood (> 99% chance) of past infection, 4.5% (n = 230) to have a 50–99% likelihood, and 4.0% (n = 203) to have a 10–49% likelihood. As different probabilistic approaches were more consistent with each other than conventional SD-based methods, such tools allow for more statistically-sound seropositivity estimates in large cohorts. Conclusion: Probabilistic antibody testing frameworks can improve seropositivity estimates in populations with large titer variability.

Ort, förlag, år, upplaga, sidor
John Wiley & Sons, 2022. Vol. 11, nr 3, artikel-id e1379
Nyckelord [en]
antibody responses, antibody testing, COVID-19, probability, SARS-CoV-2, serology
Nationell ämneskategori
Immunologi inom det medicinska området Infektionsmedicin
Identifikatorer
URN: urn:nbn:se:umu:diva-193709DOI: 10.1002/cti2.1379ISI: 000773551400002PubMedID: 35284072Scopus ID: 2-s2.0-85127258616OAI: oai:DiVA.org:umu-193709DiVA, id: diva2:1653906
Forskningsfinansiär
NIH (National Institutes of Health), 400 SUM1A44462‐02Wellcome trust, 107881Wellcome trust, 220788Vetenskapsrådet, 2017‐00968Tillgänglig från: 2022-04-25 Skapad: 2022-04-25 Senast uppdaterad: 2022-12-09Bibliografiskt granskad

Open Access i DiVA

fulltext(4412 kB)197 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 4412 kBChecksumma SHA-512
4fac6e1aab4d0f29a864ae111da41f390fa7430cd99046a4cd00f7f82a08eeb592b58b3065a6b4021dbee271d40a36ae19cb4b205285a68f74031e160db9d40b
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Vikström, LinneaForsell, Mattias N. E.

Sök vidare i DiVA

Av författaren/redaktören
Vikström, LinneaForsell, Mattias N. E.
Av organisationen
Institutionen för klinisk mikrobiologi
I samma tidskrift
Clinical & Translational Immunology (CTI)
Immunologi inom det medicinska områdetInfektionsmedicin

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 197 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 271 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf